A new analysis of online search trends shows growing interest among Americans seeking weightloss medications without visiting a doctor, prompting health experts to warn about potential risks tied to unsupervised use.
The data, compiled by nutritional support company drinktmrw.com, examined search behavior across the United States in February 2026.
Researchers tracked queries related to GLP-1 medications — including Ozempic, Wegovy and Mounjaro — alongside phrases such as “online subscription” and “no doctor appointment.”
Florida ranked highest in the nation for online interest, with about 1,477 searches per 100,000 residents each month — more than 18% above the national average. Massachusetts and Virginia followed closely behind, each recording similar levels of search activity and exceeding the national average by more than 17%.
Texas ranked fourth, with 1,465 searches per 100,000 residents, while Nevada, Illinois, California, New Jersey, Georgia and Tennessee rounded out the top 10 states.
Health professionals say the surge reflects increasing public interest in medications originally developed to treat Type 2 diabetes but now widely used for weight loss.
“We’re watching these medications change the weight loss and metabolic health conversation in real time,” said Tara Allan, a registered nurse and nutrition expert. “There’s a lot of potential there, but also a lot of oversimplification, which can be dangerous.”
Allan cautioned that GLP-1 drugs directly affect appetite, digestion and blood sugar regulation, making medical oversight critical.
“This isn’t a casual ‘order it online and see what happens’ situation,” she said, noting risks such as improper dosing, drug interactions and missed warning signs of serious side effects.
Experts also warn that reduced appetite associated with the medications can lead to nutritional deficiencies if users are not careful.
Without proper guidance, individuals may consume too little protein, vitamins and overall calories, potentially impacting muscle mass, bone density and energy levels.
Allan said warning signs of poor tolerance can include persistent nausea, fatigue, dizziness and digestive issues. She advised those using GLP-1 medications to prioritize protein intake, nutrient-dense foods and hydration, and to seek individualized medical guidance.
The findings highlight a broader trend: as demand for weight-loss solutions grows, more Americans are turning to online options that may bypass traditional health care channels — raising concerns among experts about safety and regulation.
.png)
